Canadian Online Pharmacy

CDER New

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

February 7, 2013


New and Generic Drug Approvals

February 6, 2013

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Canasa mesalamine Suppository; Rectal Aptalis Pharma Us Labeling Revision
Cetirizine Hydrochloride Allergy cetirizine hydrochloride Capsule; Oral Banner Pharmacaps Labeling Revision
Cetirizine Hydrochloride Hives Relief cetirizine hydrochloride Capsule; Oral Banner Pharmacaps Labeling Revision
Copegus ribavirin Tablet; Oral Roche Labeling Revision
Gonal-F follitropin alfa/beta Injectable; Subcutaneous Emd Serono Manufacturing Change or Addition
Gonal-F follitropin alfa/beta Injectable; Subcutaneous Emd Serono Manufacturing Change or Addition
Gonal-F Rff follitropin alfa/beta Injectable; Subcutaneous Emd Serono Manufacturing Change or Addition
Gonal-F Rff Pen follitropin alfa/beta Injectable; Subcutaneous Emd Serono Manufacturing Change or Addition
Intermezzo zolpidem tartrate Tablet; Sublingual Purdue Pharma Manufacturing Change or Addition
Lucentis ranibizumab Injectable; Injection Genentech Efficacy Supplement with Clinical Data to Support
Monistat 1 Combination Pack miconazole nitrate Cream, Suppository; Topical, Vaginal Insight Pharms Manufacturing Change or Addition
Monistat Dual- Pak miconazole nitrate Cream, Insert; Topical, Vaginal Personal Prods Manufacturing Change or Addition
Monistat-3 Combination Pack miconazole nitrate Cream, Suppository; Topical, Vaginal Insight Pharms Manufacturing Change or Addition
Pioglitazone Hydrochloride pioglitazone hydrochloride Tablet; Oral Macleods Pharms Ltd Approval
Rebetol ribavirin Capsule; Oral Merck Sharp Dohme Labeling Revision
Rebetol ribavirin Solution; Oral Schering Labeling Revision
Valsartan valsartan Tablet; Oral Dr Reddys Labs Ltd Tentative Approval
Versacloz clozapine Suspension; Oral Douglas Pharms Supplement
Zylet loteprednol etabonate; tobramycin Suspension/Drops; Ophthalmic Bausch and Lomb Efficacy Supplement with Clinical Data to Support

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery